| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $110.8M | -5.3% |
| R&D Expense | $3.8M | -20.2% |
| SG&A Expense | $16.1M | -24.9% |
| Operating Income | $9.1M | +119.4% |
| Pre-tax Income | $8.0M | +116.3% |
| Income Tax | $160K | +144.0% |
| Net Income | $7.9M | +116.1% |
| EPS (Basic) | -$0.28 | +93.2% |
| EPS (Diluted) | -$0.28 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $12.8M | +7.5% |
| Inventory | $574K | +23.4% |
| Current Assets | $24.8M | +6.7% |
| Total Assets | $71.6M | -8.0% |
| Current Liabilities | $19.6M | -16.0% |
| Long-term Debt | $336K | -96.7% |
| Total Liabilities | $21.8M | -39.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $20.6M | +33.5% |
| Capital Expenditures | $1.7M | -44.6% |
| Investing Cash Flow | -$7.4M | +36.2% |
| Financing Cash Flow | -$11.3M | +15.3% |
| Free Cash Flow | $18.9M | +52.8% |
| +93.2% |
| Stockholders' Equity |
| $49.8M |
| +19.3% |